Clinical Trials Details

Prostate Cancer

A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Hormone-Refractory Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen

Trial ID: 07179

Contact: Mary A Rauch

Phone: (281)863-4681

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
Cancer Care & Hematology Specialists of Chicagoland	Arlington Hts., IL
Texas Oncology, P.A.	Arlington, TX (South)
Central Indiana Cancer Centers	Carmel, IN
Raleigh Hematology Oncology Associates, P.C.	Cary, NC
Texas Oncology, P.A.	Dallas, TX (Sammons CC)
Central Indiana Cancer Centers	Fishers, IN
Central Indiana Cancer Centers	Greenfield, IN
Comprehensive Cancer Centers of Nevada	Henderson, NV (Siena)
Comprehensive Cancer Centers of Nevada	Henderson, NV (Wigwam)
Central Indiana Cancer Centers	Indianapolis, IN (E. County)
Central Indiana Cancer Centers	Indianapolis, IN (Rama)
Medical Oncology Associates of Wyoming Valley, PC	Kingston, PA
Comprehensive Cancer Centers of Nevada	Las Vegas, NV (Peak Dr.)
Comprehensive Cancer Centers of Nevada	Las Vegas, NV (Southern Hills)
Comprehensive Cancer Centers of Nevada	Las Vegas, NV (Twain)
Cancer Care & Hematology Specialists of Chicagoland	Niles, IL
Cancer Centers of Florida, P.A.	Ocoee, FL
Cancer Centers of Florida, P.A.	Orlando, FL (70 Gore)
Raleigh Hematology Oncology Associates, P.C.	Raleigh, NC
Raleigh Hematology Oncology Associates, P.C.	Raleigh, NC (North Raleigh)
Puget Sound Cancer Centers	Seattle, WA
Texas Oncology, P.A.	Webster, TX
Cancer Care & Hematology Specialists of Chicagoland	Winfield, IL
Cancer Centers of Florida, P.A.	Winter Park, FL (Fairbanks)